A new study found that peripheral nerve stimulation of the occipital nerve significantly reduced the number of headache days per month in patients with chronic migraine, according to a release by St. Jude Medical.
The study, presented at the 15th International Headache Congress in Berlin, tested St. Jude Medical's Genesis neurostimulator.
At one year, 66 percent of patients reported excellent or good pain relief. Patients logged a 41 percent improvement on the Migraine Disability Assessment questionnaire, compared with a 13 percent improvement in a placebo group.
Read the St. Jude Medical release on peripheral nerve stimulation.
Related Articles on Neurostimulation:
Medtronic, St. Jude Developing Competing Neurostimulation Systems
SPR Therapeutics Nabs $250K Investment for Pain Relief Device
Study: Nerve Blockade Reduces Acute Pain After Hip Fracture